The COP9 SIgnalosome in the Heart
COP9 心脏中的信号体
基本信息
- 批准号:8457106
- 负责人:
- 金额:$ 34.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-07-01 至 2016-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Dysfunction of the ubiquitin-proteasome system (UPS) and autophagy, two main intracellular proteolytic pathways, have been observed in a variety of heart diseases and implicated in the genesis of congestive heart failure (CHF), the final common pathway for virtually all heart diseases and afflicting the life of millions of Americans. The COP9 signalosome (CSN) is an evolutionarily conserved protein complex consisting of 8 unique subunits (CSN1 ~ CSN8). In the preceding competitive cycle, we have discovered that the Csn8/CSN is required for not only UPS-mediated proteolysis but also autophagy to exert their protein quality control roles in mouse hearts. Perinatal cardiomyocyte-restricted CSN subunit 8 knockout (CR-Csn8KO) causes primarily massive cardiomyocyte (CM) necrosis in intact mice and this is preceded by impairment in the autophagic- lysosomal pathway and accompanied by UPS malfunction. The CR-Csn8KO mice develop dilated cardiomyopathy and die of CHF prematurely. Building upon these exciting novel findings, we propose to decipher the molecular mechanisms by which Csn8/CSN regulates the autophagic-lysosomal pathway and cardiomyocyte survival in the heart. Using a combination of innovative genetic manipulations and pharmacological interrogations in intact mice, we will pursue three specific aims to test the central hypothesis that Csn8/CSN promotes AM via Rab7 and facilitates PQC in CMs, thereby promoting CM survival by suppressing the RIP1/RIP3-mediated necrosis pathway. Specific aim 1 defines molecular mechanisms by which Csn8/CSN promotes autophagy. This will test the hypothesis that Csn8/CSN regulates autophagosome maturation (AM) via Rab7. Specific aim 2 investigates the pathophysiological significance of autophagic activation by proteasome inhibition. This is to test the hypothesis that proteasome functional insufficiency (PFI) activates cardiac autophagy and this activation compensates for protein quality control impairment caused by PFI. Specific aim 3 tests the hypotheses that impaired AM compromises the degradation of proteasome substrates and that the duo-impairment in the UPS and autophagy triggers CM necrosis via the RIP1-RIP3 mediated pathway. The completion of this research is expected to significantly improve our understanding on how protein quality control and degradation pathways in the heart are coordinately regulated, especially by the CSN, which will facilitate the search for new strategies to prevent and/or more effectively treat CHF, a leading cause of death and disability in the US.
描述(由申请人提供):在多种心脏病中观察到了泛素蛋白 - 蛋白酶体系统(UPS)和自噬的功能障碍,这是两种主要的细胞内蛋白水解途径,并参与了各种心脏病的生成(CHF)的生成(CHF),这是针对美国全心全意疾病的最终共同途径,是全心疾病的最终公共路径,使美国的生活和米尔群岛的生命与Millions and Millions and Millions and Millions and Millions and Millions。 COP9信号体(CSN)是一种进化保守的蛋白质复合物,由8个独特的亚基(CSN1〜CSN8)组成。在前面的竞争周期中,我们发现CSN8/CSN不仅需要UPS介导的蛋白水解,而且还需要自噬才能在小鼠心脏中发挥其蛋白质质量控制作用。围产期心肌细胞限制的CSN亚基8基因敲除(CR-CSN8KO)主要是完整小鼠中主要是大规模的心肌细胞(CM)坏死,这是自噬 - 肌瘤途径的损害,并伴有UPS功能不全。 CR-CSN8KO小鼠会出现扩张的心肌病,过早地死于CHF。在这些令人兴奋的新发现的基础上,我们建议破译CSN8/CSN调节心脏中自噬溶质体途径和心肌细胞存活的分子机制。使用完整小鼠中创新的遗传操作和药理学询问的结合,我们将追求三个特定的目标,以测试CSN8/CSN通过RAB7促进AM的中心假设,并促进CMS中的PQC,从而通过抑制RIP1/RIP3/RIP3介导的Necrise pation促进CM生存。特定目标1定义了CSN8/CSN促进自噬的分子机制。这将检验以下假设:CSN8/CSN通过RAB7调节自噬体成熟(AM)。具体目标2研究了通过蛋白酶体抑制作用自噬激活的病理生理学意义。这是为了测试蛋白酶体功能不全(PFI)激活心脏自噬的假设,而这种激活可以补偿由PFI引起的蛋白质质量控制障碍。特定的目标3检验了损害AM的假设损害了蛋白酶体底物的降解,并且UPS和自噬中的二人损伤通过RIP1-RIP3介导的途径触发了CM坏死。预计这项研究的完成将显着提高我们对蛋白质质量控制和心脏中蛋白质质量控制途径的理解,特别是通过CSN进行协调调节,这将有助于寻找新的策略,以预防和/或更有效地治疗CHF,这是美国主要的死亡和残疾原因。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
XUEJUN WANG的其他基金
Priming the proteasome to protect against aging and Alzheimer's disease
启动蛋白酶体以预防衰老和阿尔茨海默病
- 批准号:1044814610448146
- 财政年份:2022
- 资助金额:$ 34.48万$ 34.48万
- 项目类别:
Cardiac Pathophysiology of Proteasome Phosphoregulation
蛋白酶体磷酸调节的心脏病理生理学
- 批准号:1022433610224336
- 财政年份:2020
- 资助金额:$ 34.48万$ 34.48万
- 项目类别:
Cardiac Pathophysiology of Proteasome Phosphoregulation
蛋白酶体磷酸调节的心脏病理生理学
- 批准号:1003351710033517
- 财政年份:2020
- 资助金额:$ 34.48万$ 34.48万
- 项目类别:
Cardiac Pathophysiology of Proteasome Phosphoregulation
蛋白酶体磷酸调节的心脏病理生理学
- 批准号:1062794810627948
- 财政年份:2020
- 资助金额:$ 34.48万$ 34.48万
- 项目类别:
Cardiac Pathophysiology of Proteasome Phosphoregulation
蛋白酶体磷酸调节的心脏病理生理学
- 批准号:1043549110435491
- 财政年份:2020
- 资助金额:$ 34.48万$ 34.48万
- 项目类别:
Molecular Pathogenesis of Protein Surplus Cardiomyopathy
蛋白质过剩心肌病的分子发病机制
- 批准号:78223537822353
- 财政年份:2009
- 资助金额:$ 34.48万$ 34.48万
- 项目类别:
SD COBRE: UBIQUITIN-PROTEASOME IN CARDIAC REMODELING AND FAILURE
SD COBRE:泛素蛋白酶体在心脏重构和衰竭中的作用
- 批准号:77206477720647
- 财政年份:2008
- 资助金额:$ 34.48万$ 34.48万
- 项目类别:
The COP9 Signalosome in the Heart
COP9 心脏中的信号体
- 批准号:74337567433756
- 财政年份:2006
- 资助金额:$ 34.48万$ 34.48万
- 项目类别:
The COP9 SIgnalosome in the Heart
COP9 心脏中的信号体
- 批准号:88005678800567
- 财政年份:2006
- 资助金额:$ 34.48万$ 34.48万
- 项目类别:
The COP9 Signalosome in the Heart
COP9 心脏中的信号体
- 批准号:76312617631261
- 财政年份:2006
- 资助金额:$ 34.48万$ 34.48万
- 项目类别:
相似国自然基金
采空区瓦斯爆炸火焰在垮落岩体间的加速与衰减特性研究
- 批准号:52304267
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多分量背景噪声高阶面波频散与衰减的提取和联合反演研究
- 批准号:42304065
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多组学技术解析NK细胞免疫应答在HIV病毒库衰减中的作用和机制研究
- 批准号:82371766
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
锂合金负极微观电化学行为对负极内界面离子输运及容量衰减的作用机理
- 批准号:12304029
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
非均质砂岩散射衰减实验测量与微结构散射效应解析
- 批准号:42304144
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Cardiac Macrophage Plasticity in Sepsis-induced Cardiomyopathy
脓毒症引起的心肌病中心脏巨噬细胞的可塑性
- 批准号:1072817510728175
- 财政年份:2023
- 资助金额:$ 34.48万$ 34.48万
- 项目类别:
Interplay of processed diet, gut microbiota, and interferon-linked mucosal immunity in the onset and prevalence of inflammatory bowel disease
加工饮食、肠道微生物群和干扰素相关粘膜免疫在炎症性肠病发病和患病率中的相互作用
- 批准号:1065874110658741
- 财政年份:2023
- 资助金额:$ 34.48万$ 34.48万
- 项目类别:
Regulation of Cardiac Metabolic Plasticity in Sepsis
脓毒症心脏代谢可塑性的调节
- 批准号:1062940110629401
- 财政年份:2022
- 资助金额:$ 34.48万$ 34.48万
- 项目类别:
Regulation of Cardiac Metabolic Plasticity in Sepsis
脓毒症心脏代谢可塑性的调节
- 批准号:1052751510527515
- 财政年份:2022
- 资助金额:$ 34.48万$ 34.48万
- 项目类别:
STING agonist-expressing BCG for bladder cancer
表达 STING 激动剂的 BCG 用于治疗膀胱癌
- 批准号:1032512510325125
- 财政年份:2021
- 资助金额:$ 34.48万$ 34.48万
- 项目类别: